The QualityStocks Daily Tuesday, September 10th, 2024

Today's Top 3 Investment Newsletters

MarketClub Analysis(QH) $1.3300 +306.60%

QualityStocks(BKYI) $2.0000 +97.04%

Premium Stock Alerts(SMX) $3.2900 +48.53%

The QualityStocks Daily Stock List

BIO-Key International (BKYI)

QualityStocks, MarketBeat, StockMarketWatch, StockEarnings, InvestorPlace, Marketbeat.com, PennyStocks24, SmallCapVoice, Daily Trade Alert, The Online Investor, Journal Transcript, InvestorsUnderground, Financials Trend, FeedBlitz, Buzz Stocks, HotStockChat, Penny Pick Finders, BUYINS.NET, Planet Penny Stocks, Zacks, RedChip, SecretStockPromo, SeeThruEquity Research, Stock News Now, StockOnion, Total Wealth, Trades Of The Day and PennyStockProphet reported earlier on BIO-Key International (BKYI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

BIO-Key International, Inc. (NASDAQ: BKYI) (FRA: BJO) is a fingerprint biometric technology firm that is focused on developing and marketing fingerprint identification biometric tech, software solutions and identity access management solutions.

The firm has its headquarters in Wall, New Jersey and was incorporated in 1993, on January 7th. Prior to its name change in 2002, the firm was known as SAC Technologies. It serves consumers around the globe.

The company is organized around one primary operating segment called Biometric products. Its capabilities prevent false identities via hardware independence and alias checks. It generates its revenue in the form of license fees, services and others. The company mainly serves education, government and commercial consumers both internationally as well as in the United States.

The enterprise’s products include a neutral-by-design consumer-controlled cloud-based identity platform dubbed PortalGuard IDaaS and PortalGuard which enable consumers to integrate with any on-premise software-as-a-service app or cloud, as well as Windows device authentication. Its solutions make their partner networks more collaborative and allow consumers to secure their student populations and workforces. It also offers large-scale and civil ID infrastructure solutions to develop finger-based biometric technology, Web-key and Bio-key VST products. In addition to this, the enterprise provides finger scanners for consumer and enterprise markets under the SidePass, EcoID and SideSwipe brands.

The firm recently announced the commencement of a partner program with scansource firm Intelisys. This relationship will help expand Bio-Key’s Channel Alliance partner program and improve its security practice. This is in addition to extending its consumer reach, which will be good for revenue and investments into the firm.

BIO-Key International (BKYI), closed Tuesday's trading session at $2, up 97.0443%, on 146,559,396 volume. The average volume for the last 3 months is 109,042 and the stock's 52-week low/high is $1.0019/$10.7982.

Sitka Gold (SITKF)

We reported earlier on Sitka Gold (SITKF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Sitka Gold Corp (OTCQB: SITKF) (CNSX: SIG) (FRA: 1RF) is a mineral exploration firm focused on exploring for minerals at resource properties in the U.S. and Canada.

The firm has its headquarters in Vancouver, Canada and was incorporated in 2015, on January 13th. It operates as part of the gold industry, under the basic materials sector. The firm serves consumers around the globe.

The company explores for gold, zinc, silver, and copper deposits. It owns interests in the OGI property, which comprises of 99 quartz mining claims located in Dawson City, Yukon; the Coppermine River project, which covers an area of about 50,000 hectares and is located in Nunavut; the RC Gold property, which comprises of 1,891 claims that cover an area of approximately 37,600 hectares situated in Yukon; and the Alpha Gold property, which includes 293 claims that covers an area of approximately 4780 acres situated in Eureka County, Nevada. The company also holds an option to acquire a 100% interest in the Burro Creek property, which covers an area of about 750 hectares. This property includes 4 patented mineral claims and 35 surrounding lode mineral claims located in the Mohave County, Arizona. It also holds an option to acquire interest in the Barney Ridge property situated to the east of Dawson City, Yukon. In addition to this, it holds a 100% interest in the Mahtin property, which comprises 1,447 quartz mining claims that cover an area of 30,242 hectares located in Yukon territory; and the Clear Creek Gold property, located to the east of Dawson City, Yukon.

The firm, which recently drilled over 1.34 million ounces of gold in two major deposits, is focused on accelerating exploration efforts at its properties as well as furthering development. This may positively influence shareholder value.

Sitka Gold (SITKF), closed Tuesday's trading session at $0.191725, up 23.6935%, on 556,350 volume. The average volume for the last 3 months is 127,295 and the stock's 52-week low/high is $0.0901/$0.194.

Better Choice Company (BTTR)

QualityStocks, StockEarnings, RedChip, StockWireNews, Small Cap Firm, PoliticsAndMyPortfolio, Fierce Analyst, Weekly Newsletter, Top Pros' Top Picks, Red Chip, MarketBeat, Investors Underground and FreeRealTime reported earlier on Better Choice Company (BTTR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Better Choice Company Inc. (NYSE American: BTTR) is an animal health and wellness firm which is focused on the provision of premium treats, foods and supplements for animals.

The firm has its headquarters in Oldsmar, Florida and was incorporated in 2001, on January 3rd. It operates as part of the other miscellaneous store retailers’ industry. The firm has five companies in its corporate family and serves consumers in Asia, Australia, Canada and the United States.

The company takes a nutrition-based alternative approach to animal health relative to conventional cat and dog food offering. It is focused on positioning its portfolio of brands to benefit from consumer focus on health and wellness and mainstream trends of increasing pet humanization. The company is committed to leading the industry shift toward pet services and products that help cats and dogs live longer, happier and healthier lives.

The enterprise provides vegan dog treats and food, freeze-dried raw dog treats and food, canned cat and dog food, naturally formulated premium kibble, raw-diet dog treats and food, supplements, oral care products and grooming aids. It offers its products for cats, dogs and pet parents under the Rawgo! TruDog and Halo brand name. The enterprise mainly sells its products through pet specialty stores and online retailers, as well as through its online portal.

The company recently entered into a nationwide distribution agreement with Phillips Pet Food & Supplies, to launch a new natural pet food brand known as Halo Elevate. This move will facilitate the delivery of Better Choice’s high quality pet products and food across Phillips’ extensive distribution network, which will help extend the company’s consumer reach and bring in additional revenue.

Better Choice Company (BTTR), closed Tuesday's trading session at $2.82, up 21.03%, on 86,972 volume. The average volume for the last 3 months is 28,851 and the stock's 52-week low/high is $1.92/$25.52.

IZEA Worldwide (IZEA)

QualityStocks, RedChip, StockMarketWatch, MarketBeat, MarketClub Analysis, BUYINS.NET, Wall Street Resources, TraderPower, TradersPro, InvestorPlace, TheMicrocapNews, Marketbeat.com, Daily Trade Alert, SeeThruEquity Research, Greenbackers, Promotion Stock Secrets, Bullish Bankers, InsiderTrades, Trades Of The Day, Stock Exploder, VIP STOCK ALERTS, Trading Concepts, TopStockAnalysts, HEROSTOCKS, StreetInsider, Stockhunter.us, Red Chip, Liquid Pennies, Small Cap Firm, Stock Edge, SmallCap Network, OTC Showcase, PennyStockProfessor, PennyStocks24, Perfect Penny Stocks, BullDogReporter and InvestorsUnderground reported earlier on IZEA Worldwide (IZEA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

IZEA Worldwide Inc. (NASDAQ: IZEA) (FRA: 2IZ) is an online marketplace that connects marketers with content creators that distribute and produce photos, videos and text for social media channels, blogs and marketers, under its IZEAx platform.

IZEA Worldwide is part of the advertising agencies industry and operates as an online media marketing firm. The firm serves consumers around the globe and operates through the SaaS services and managed services segments.

IZEA Worldwide Inc. has its headquarters in Winter Park, Florida and was incorporated in 2006 February by Edward Hans Murphy. The firm was known as IZEA Inc. before changing its name in 2018. The company mainly sells influencer content and marketing campaigns through the TapInfluence, Shake, BrandGraph and IZEAx Exchange platforms, as well as through sales teams.

It offers its services to different industries, which include the travel, technology, retail/eTail and consumer products industries in various countries, including the United Kingdom, India, Canada and the United States. The firm’s technology solutions allow the management of content workflow, payment processing, analytics, bidding and creator search and targeting. The company also automates the development of custom content and influencer marketing, which enables agencies and brands to scale up their marketing programs.

IZEA Worldwide Inc. recently reported that they had observed a 130% jump in their managed services bookings and with a clear momentum building for managed services, the firm is bound to experience significant growth in the near future. This move will result in considerable investments, which will be good for the firm’s stockholders.

IZEA Worldwide (IZEA), closed Tuesday's trading session at $2.45, up 14.486%, on 153,518 volume. The average volume for the last 3 months is 290,187 and the stock's 52-week low/high is $1.83/$3.60.

Corvus Pharmaceuticals (CRVS)

MarketBeat, MarketClub Analysis, StreetInsider, StockMarketWatch, QualityStocks, Schaeffer's, Zacks, BUYINS.NET, TopPennyStockMovers, TraderPower, The Street, PoliticsAndMyPortfolio, Penny Stock, TradersPro, Trades Of The Day and InsiderTrades reported earlier on Corvus Pharmaceuticals (CRVS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Corvus Pharmaceuticals Inc. (NASDAQ: CRVS) (FRA: C17) is a clinical stage biopharmaceutical firm that is focused on developing and commercializing immune-oncology therapies.

The firm has its headquarters in Burlingame, California and was incorporated in 2014, on January 27th by Joseph J. Buggy, Peter A. Thompson and Richard A. Miller. It operates as part of the pharmaceutical and medicine manufacturing industry, under the health care sector.

The company is party to a strategic collaboration with Angel Pharmaceuticals Ltd, which entails developing its pipeline of investigational medicines. The company serves consumers in the United States.

The enterprise’s product pipeline comprises of an oral small molecule A2A receptor antagonist dubbed CPI-444, which is undergoing a phase 2 clinical trial for adenosine; a covalent ITK inhibitor known as CPI-818, which is in a phase 1 clinical trial evaluating its effectiveness in treating individuals with malignant T-cell lymphomas; and an anti-CD73 monoclonal antibody dubbed CPI-006, which is undergoing a phase 3 trial for coronavirus as well as a phase 1 trial that activates different immune cells and inhibits adenosine production. The enterprise’s pre-clinical stage products include an adenosine A2B receptor antagonist dubbed CPI-935, which is indicated for fibrosis prevention; and an antibody known as CPI-182, which has been designed to block myeloid derived suppressor cells as well as neutrophil migration and function.

An Investigational New Drug application submitted by the company’s partner Angel Pharmaceuticals for their CPI-818 formulation has been accepted by the China National Medical Products Administration Center for Drug Evaluation. The success and approval of the formulation for use in treating relapsed/refractory T-cell lymphomas will benefit patients as well as bring in more revenues and investors into both companies.

Corvus Pharmaceuticals (CRVS), closed Tuesday's trading session at $4.635, up 13.8821%, on 580,628 volume. The average volume for the last 3 months is 48,228 and the stock's 52-week low/high is $1.05/$4.75.

Benson Hill Inc. (BHIL)

QualityStocks, MarketBeat, FreeRealTime, Zacks, StockEarnings and Premium Stock Alerts reported earlier on Benson Hill Inc. (BHIL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Benson Hill Inc. (NYSE: BHIL) is a food technology firm that has developed a technology platform which combines food and plant sciences, and data to create ingredient, feed and food products.

The firm has its headquarters in Louis, Missouri and was incorporated in 2012. Prior to its name change, the firm was known as Benson Hill Biosystems Inc. The firm serves consumers around the globe.

The company is focused on the development of a portfolio made up of 4 markets, i.e. fresh produce, vegetable oils, animal feed and plant-based foods. It operates through the Fresh Business, and the Ingredients Business segments. The former segment operates through the company’s J&J Produce Inc. subsidiary that is involved in the sale of fresh produce products to retail customers. On the other hand, the latter segment provides a pipeline of yellow pea products and soy products, including ultra-high protein soybeans, animal feed and differentiated soy-based vegetable oils.

The enterprise’s technology platform, CropOS, uses data, artificial intelligence, predictive breeding and other advanced breeding methods like CRISPR gene editing technology, which combine food and plant sciences and data to create crops optimized for yield, flavor and nutrition. It serves logistics consolidators, farmers, seed producers, breeders, food and beverage companies, processors, wholesale suppliers and consumers, as well as food service retailers.

The company recently acquired ZFS Creston LLC, which manufactures soy and white flake flour. This acquisition will position the company for a more profitable revenue source in the futureby allowing it to scale up its plant-based protein ingredients commercialization.

Benson Hill Inc. (BHIL), closed Tuesday's trading session at $6.99, up 12.0192%, on 85,535 volume. The average volume for the last 3 months is 119,164 and the stock's 52-week low/high is $4.41175/$23.10.

A2Z Cust2Mate Solutions (AZ)

Mark Soberman, StockWireNews, StockStreetWire, Small Cap Firm, QualityStocks, Fierce Analyst, TradersPro, The Wealth Report, StockHideout, ProTrader, MarketBeat and InvestorPlace reported earlier on A2Z Cust2Mate Solutions (AZ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) (FRA: A230) is a technology firm engaged in developing and commercializing retail smart cart solutions for supermarkets and grocery stores.

The firm has its headquarters in Vancouver, Canada and was incorporated in 2018, on January 15th by Joseph Bentsur. Prior to its name change, the firm was known as A2Z Smart Technologies Corp. It operates as part of the software-application industry, under the technology sector. The firm serves consumers around the globe, with a focus on those in Israel.

The enterprise operates through the Precision Metal Parts, Advanced Engineering, and Smart Carts segments. It develops Fuel Tank Inertia Capsule System technology (FTICS), a vehicle device cover for the military and civilian automotive industry; and manufactures and sells precision metal parts. It also offers retail automation solutions; the Cust2Mate system, which incorporates a smart cart that automatically calculates the value of the customer’s purchases in their smart cart without having to unload and reload their purchases at a customer checkout point; and maintenance services utilizing the application of advanced engineering capabilities to the military and security markets. In addition, it develops related products for the civilian and retail markets; and offers container leasing services as well as maintenance services for complex electronic systems and products. The enterprise sells its products to grocery stores, discount stores, do it yourself (DIY) retailers, convenience stores, hardware stores, household essentials shops, duty free shops, warehouse stores, drug stores, and similar outlets.

A2Z Cust2Mate Solutions (AZ), closed Tuesday's trading session at $0.6151, up 11.411%, on 61,312 volume. The average volume for the last 3 months is 13.173M and the stock's 52-week low/high is $0.34/$1.97.

Alibaba Group Holding Ltd. (BABA)

InvestorPlace, The Street, Kiplinger Today, Schaeffer's, MarketClub Analysis, Zacks, Money Morning, StreetInsider, Trades Of The Day, Daily Trade Alert, Marketbeat, Market Intelligence Center Alert, StocksEarning, Investopedia, The Online Investor, Wealth Insider Alert, StreetAuthority Daily, Early Bird, ProfitableTrading, CustomerService, Marketbeat.com, TopStockAnalysts, Louis Navellier, Uncommon Wisdom, GorillaTrades, QualityStocks, TipRanks, StockEarnings, Top Pros' Top Picks, Cabot Wealth, CNBC Breaking News, Profit Confidential, AllPennyStocks, The Wealth Report, Options Elite, Investors Alley, Total Wealth, Daily Profit, INO.com Market Report, Street Insider, Money and Markets, Wyatt Investment Research, Barchart, The Street Report, SmallCapVoice, StrategicTechInvestor, Investing Daily, Insider Wealth Alert, Market Intelligence Center, Daily Wealth, Power Profit Trades, Average Joe Options, Investing Signal, FreeRealTime, Trade of the Week, Wealth Daily, INO Market Report, MarketTamer, WStreet Market Commentary, Trading Concepts, Trader Prep, BUYINS.NET, MarketWatch, Short Term Wealth, Wall Street Daily, The Best Newsletters, Earnings360, Dynamic Wealth Report, InvestmentHouse, ChineseWire, Rick Saddler, 24/7 Trader, Visual Capitalist, Inside Investing Daily, TheOptionSpecialist, Wealthpire Inc., Investing Lab, InvestorsHQ, Energy and Capital, Investment U, Investing Futures, SureMoney, Investors Underground, OptionAlarm News, Agora Financial, MarketArmor.com, The Weekly Options Trader, Daily Dividends, Goldman Small Cap Research, Beat The Street, BillionDollarClub, wealthmintrplus, Financial Freedom Post, Atomic Pennies, 24-7 Stock Alert, Equities.com, Direction Alerts, Dividend Opportunities, DividendStocks, Energy & Resources Digest, Eagle Financial Publications, wyatt research newsletter, Wallstreet Journal, The Trading Report, The Stock Dork, The Night Owl, The Growth Stock Wire, Terry's Tips, Summa Money, StockReport, StockMarketWatch, Stock Gumshoe, SmallCapNetwork, Shah's Insights & Indictments, Rockwell Trading, Profits Run, InvestorsObserver Team, MarketDeal, Hit and Run Candle Sticks, Inside Trading, Investiv, Investment House, Weekly Wizards, Outsider Club, InvestorGuide, Navellier Growth, Jim Cramer, TheoTrade, Kiplinger’s Weekly Update, Liberty Through Wealth, Market Authority, Greenbackers and Investor Guide reported earlier on Alibaba Group Holding Ltd. (BABA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Alibaba Group Holding Ltd. (NYSE: BABA) has established a new digital tech firm within e-commerce outfit Taobao and Tmall Group (TTG) to further its goal of expanding its share of the global market: the Hangzhou Taobao and Tmall Digital Technology Company. The new technology company has a registered capital base of $1.4 million (10 million yuan) and will be involved in a variety of businesses. This includes outdoor products, food sales, export and import of products, household appliances, daily groceries and tech-related services such as technology transfer and software development.

The new technology company was registered on Aug. 23, 2024, shortly after Alibaba successfully showcased its artificial assistance (AI)-assisted cloud broadcasting technology at the Paris 2024 Olympic Games. The entity’s formation also comes after Alibaba shut down its cloud facilities in Australia to focus its attention on the South American and Asian markets.

Furthermore, Hangzhou Taobao and Tmall Digital Technology Co. was formed days after the State Administration for Market Regulation, China’s antitrust watchdog, ended its three-year regulatory audit of Alibaba. Although Alibaba Group’s e-commerce subsidiaries already cover most of these activities, Hangzhou Taobao and Tmall Digital Technology Co could provide Alibaba with opportunities to increase its focus on certain business pursuits or pursue additional expansion.

Beijing is currently scrambling to increase investor confidence in its private sector as a major slump in the property market coupled with reduced consumer spending threatens to prevent the country from reaching its 2024 economic growth target of 5%. Despite its dominance in the Chinese market, TTG has faced increasingly stiff competition from Chinese company JD.com and newer entrants into the e-commerce space including ByteDance’s Douyin and PDD Holdings-owned Pinduoduo.

A domestic price war broke out in July when both Douyin and TTG implemented policies that adjusted their business strategies to low-cost retail products, a recent report says. As one of the largest players in China’s e-commerce space through its subsidiaries Taobao and Tmall Group, pundits often see Alibaba’s revenue as a metric for measuring consumer spending and economic health in China.

Unfortunately, the group missed its fiscal topline growth projections for the first quarter by $1.33 billion while TTG’s revenue fell by 1% to $15.60 billion and the net income declined by 29% year-over-year to $3.34 billion. Alibaba’s stock has also decreased by more than 13% during the last year, thanks to the State Administration for Market Regulation’s three-year-long probe, increasing competition in the domestic market, and weak consumer spending.

Alibaba Group Holding Ltd. (BABA), closed Tuesday's trading session at $83.8, up 2.8978%, on 15,327,768 volume. The average volume for the last 3 months is 35.801M and the stock's 52-week low/high is $66.63/$90.46.

Lucid Group (LCID)

Green Car Stocks, InvestorPlace, Schaeffer's, StockEarnings, QualityStocks, MarketClub Analysis, The Street, Early Bird, MarketBeat, GreenCarStocks, StocksEarning, Investopedia, INO Market Report, BillionDollarClub, Daily Trade Alert, Kiplinger Today, Trades Of The Day, Money Wealth Matters, The Online Investor, Premium Stock Alerts, The Wealth Report, Louis Navellier, DividendStocks, FreeRealTime, Green Energy Stocks, The Night Owl, Zacks, InsiderTrades, Smartmoneytrading, InvestorsUnderground, Earnings360, Top Pros’ Top Picks, 360 Wall Street, Cabot Wealth, Wealth Whisperer, AllPennyStocks and The Stock Dork reported earlier on Lucid Group (LCID), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Lucid Group (NASDAQ: LCID), maker of the world's most-advanced electric vehicles, is showcasing its Lucid Gravity SUV today during its Technology & Manufacturing Day. According to the announcement, the event is being held at the company’s Arizona factory. In addition to highlighting the new EV, the event provided an overview of the car’s enabling technologies as well as an independent third-party analysis of the cost effectiveness of manufacturing the  innovations. The company also announced its next-generation drive unit, Atlas, which is in development and undergoing extensive testing, and also reported that so far this year, it has delivered more cars than in all of 2023.

“Today demonstrates how the Lucid Gravity is set to be the best SUV ever, showcasing its revolutionary package and attributes only made possible with the technologies Lucid has pioneered,” said Lucid CEO and CTO Peter Rawlinson in the press release. “Our drive unit is one of several important enabling technologies, delivering next-level performance, collectively enabling a lower cost for our powertrain system than our competitors. Simply put, our vehicles go farther with less, unlocking significant cost and mass savings as we scale.”

To view the full press release, visit https://ibn.fm/fN9yZ

About Lucid Group Inc.

Lucid is a Silicon Valley-based technology company focused on creating the most advanced EVs in the world. Its flagship vehicle, Lucid Air, delivers best-in-class performance and efficiency starting at $69,900 in the United States. Lucid is preparing its state-of-the-art, vertically integrated factory in Arizona to begin production of the Lucid Gravity SUV. The company's goal is to accelerate humanity's transition to sustainable transportation and energy. For more information about the company, visit www.LucidMotors.com.

Lucid Group (LCID), closed Tuesday's trading session at $3.53, up 2.0231%, on 27,925,354 volume. The average volume for the last 3 months is 25.138M and the stock's 52-week low/high is $2.29/$6.12.

Alphabet (GOOGL)

The Street, InvestorPlace, Kiplinger Today, Zacks, The Online Investor, Schaeffer's, Daily Trade Alert, Investopedia, Trades Of The Day, Market Intelligence Center Alert, Money Morning, Early Bird, MarketBeat, MarketClub Analysis, StreetInsider, Uncommon Wisdom, StreetAuthority Daily, Wealth Insider Alert, Top Pros' Top Picks, Daily Profit, StrategicTechInvestor, Wyatt Investment Research, The Street Report, Wall Street Daily, The Wealth Report, TopStockAnalysts, Money and Markets, CustomerService, AllPennyStocks, Louis Navellier, MarketWatch, StocksEarning, All about trends, Investing Daily, Daily Wealth, TipRanks, ProfitableTrading, Stansberry Research, CNBC Breaking News, INO.com Market Report, Marketbeat.com, Investors Alley, INO Market Report, MarketTamer, MarketArmor.com, Market Intelligence Center, QualityStocks, Darwin Investing Network, Trading Tips, Power Profit Trades, InvestorGuide, Stock Up Featured, InsiderTrades, Options Elite, Barchart, InvestorIntel, DividendStocks, Money Wealth Matters, Cabot Wealth, Total Wealth, The Night Owl, StockEarnings, SmallCapNetwork, Daily Dividends, GorillaTrades, TheOptionSpecialist, WStreet Market Commentary, FreeRealTime, The Daily Market Alert, Insider Wealth Alert, Jon Markman’s Pivotal Point, Dynamic Wealth Report, Investiv, Investing Futures, Trader Prep, The Weekly Options Trader, Investing Signal, Investor Guide, InvestorsObserver Team, Eagle Financial Publications, SmallCap Network, Short Term Wealth, Smartmoneytrading, StockMarketWatch, The Motley Fool, Trading Concepts, Chaikin PowerFeed, Average Joe Options, Market Authority, Trade of the Week, 24/7 Trader, Investing Lab, Jim Cramer, Wealth Daily, TradingPub, Equities.com, The Wall Street Transcript, Investment House, Shah's Insights & Indictments, Financials Trends, Inside Investing Daily, Investing Breakout, Investment U, Earnings360 Newsletter, Stock Barometer, TrendAdvisor, Tradespoon, TradeSmith Daily, Traders For Cash Flow, Top Pros Top Picks, The Trading Report, The Stock Dork, RedChip, BUYINS.NET, ChartAdvisor, Profit Confidential, Lance Ippolito, Mind Over Markets, StockReport, Pennystockmania, CNBC, Contrarian Outlook, Schaeffer’s, bullseyeoptiontrading, BillionDollarClub, Beat The Street, empirefinancialresearch, Earnings360, 360 Wall Street, Day Trade Alert, Candle Stick Forum, Energy and Capital, Economic News Room, Dividend Opportunities, Energy & Resources Digest, StreetAuthority Financial, Rockwell Trading, Roundtable Roundup, SECFilings.com News, SmallCapVoice, Smart Investing Today, Smart Money Press, SmartTrading, Microcapmillionaires, Street Insider, PoliticsAndMyPortfolio.com, Summa Money, SwingTradeOnline, SystemTrading, Technology Profits Daily, Tim Bohen, Tim Sykes, wyatt research newsletter, Stock Gumshoe, Liberty Through Wealth, Greenbackers, HotStockProfits and iDigital Market reported earlier on Alphabet (GOOGL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Alphabet (NASDAQ: GOOGL, GOOG), the parent company of Google, has faced a significant legal setback as the Court of Justice of the European Union upheld a hefty fine of 2.4 billion euros (approximately $2.7 billion) for abusing its dominant market position. This ruling is a result of the European Commission’s antitrust investigation, which concluded in 2017, finding that Google favored its own shopping comparison service over those of its competitors. This decision highlights the European Union’s strict regulatory stance on antitrust issues, especially concerning tech giants.

Despite this legal challenge, Alphabet Inc.’s financial performance remains robust. The company’s stock price recently reached $149.105, reflecting a slight increase of $0.395 or approximately 0.27%. This trading session saw the stock fluctuating between a low of $149.015 and a high of $151.255. Over the past year, GOOGL’s stock has experienced significant volatility, with prices ranging from a low of $120.21 to a high of $191.75. This volatility underscores the dynamic nature of the tech industry and the various factors that can influence a company’s stock performance.

Alphabet Inc.’s market capitalization stands at an impressive approximately $1.84 trillion, indicating the company’s substantial value and influence in the global market. With a trading volume of 9,745,113 shares, it’s clear that Alphabet Inc. remains a highly traded company, reflecting investor interest and confidence in its long-term prospects. This financial strength and market position suggest that while the EU’s fine is a setback, Alphabet Inc. has the resources to manage such challenges.

The EU’s ruling against Google serves as a reminder of the ongoing regulatory challenges faced by tech giants in Europe. The European Union’s stringent antitrust stance aims to ensure fair competition and prevent market dominance abuses. For Alphabet Inc., navigating these regulatory waters will be crucial in maintaining its leading position in the global tech industry.

To view the company’s latest earnings release, visit https://ibn.fm/1vFFk

About Alphabet Inc.

Alphabet is a collection of companies, the largest of which is Google. Larry Page and Sergey Brin founded Google in September 1998 and the company is headquartered in Mountain View, California. Billions of people use its wide range of popular products and platforms each day, like Search, Ads, Chrome, Cloud, YouTube and Android. For more information, visit the company’s website at www.ABC.xyz.

Alphabet (GOOGL), closed Tuesday's trading session at $148.66, off by 0.0336225%, on 31,118,765 volume. The average volume for the last 3 months is 335,774 and the stock's 52-week low/high is $120.2057/$191.75.

Trulieve Cannabis Corp. (TCNNF)

QualityStocks, InvestorPlace, MarketBeat, Wealth Insider Alert, Daily Trade Alert, Cabot Wealth, Top Pros' Top Picks, The Street, CannabisNewsWire, Trades Of The Day, Profit Trends, TradersPro, The Online Investor, StreetInsider and Prism MarketView reported earlier on Trulieve Cannabis Corp. (TCNNF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The U.S. marijuana industry, valued at $32.1 billion, entered Labor Day weekend for the second consecutive year with significant developments regarding the Biden administration’s attempts to change marijuana’s classification. Despite this milestone, the reaction has been one of disappointment rather than celebration, following the recent announcement that a crucial hearing about cannabis rescheduling won’t take place until December. This delay led to frustration and a slight dip in cannabis stock values.

Last year, the industry had a more optimistic outlook during this period as federal health regulators had recommended recognizing cannabis as medicine, a major step forward in marijuana reform. However, this year brings a less favorable situation as Anne Milgram, chief of the U.S. Drug Enforcement Administration (DEA), issued a notice in the Federal Register announcing a Dec. 2, 2024, hearing, signaling that the rescheduling of marijuana is unlikely to occur before 2025. Consequently, cannabis businesses will need to wait a while longer for potential tax relief at the federal level.

Representative Earl Blumenauer, cochair of the Congressional Marijuana Caucus, expressed his dissatisfaction, accusing the DEA of holding up progress on a matter that the White House considers important. On the other hand, some observers, such as Shawn Hauser of the legal firm Vicente, say they expected these kinds of delays and pointed out that a hearing was always a real possibility.

Blumenauer’s disappointment mirrors the sentiments of many in the marijuana industry, including prominent entities such as  Green Thumb CEO Ben Kovler, who voiced his frustration on social media. The market responded accordingly, with Green Thumb’s stock dropping by more than 8.5%, while other major cannabis companies, including Curaleaf Holdings, Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) and Verano Holdings, experienced similar declines.

The cannabis community’s disappointment spilled onto social media, with industry leaders and advocates expressing their discontent with President Biden, Milgram and even among themselves. Speculation also arose that a potential Republican presidential win, particularly by Donald Trump, could undo the rescheduling process. However, these are only rumors with no factual backing.

Industry insiders, including lobbyists, lawyers and some marijuana executives argue that the December hearing should not be surprising, emphasizing that the rescheduling process initiated by Biden’s executive order in October 2022 remains on track.

The final rule publication will follow the administrative law judge’s hearing, although no specific timeline is mandated by the Administrative Procedure Act. Barring any extended legal challenges, a final decision could still be made before Biden’s term ends on Jan. 25, 2025.

The specifics of who will participate in the December hearing remain unclear. As the industry prepares its case, experts anticipate a showdown with familiar opponents such as Smart Approaches to Cannabis.

Trulieve Cannabis Corp. (TCNNF), closed Tuesday's trading session at $10.97, off by 1.7905%, on 343,381 volume. The average volume for the last 3 months is 1.188M and the stock's 52-week low/high is $3.79/$14.50.

Mind Medicine Inc. (MNMD)

QualityStocks, InvestorPlace, Schaeffer's, PsychedelicNewsWire, MarketBeat, TradersPro, The Wealth Report, The Street, The Stock Dork, MarketClub Analysis, Daily Trade Alert, Wealth Daily and Trades Of The Day reported earlier on Mind Medicine Inc. (MNMD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Interest in psychedelics has increased significantly these last few years, with researchers finding out more about the potential mental health benefits of substances such as LSD, mescaline, DMT and psilocybin. Thus far, research has determined that these drugs induce intense emotional experiences and alter individuals’ perception and cognition, with some also causing mystical experiences.

Now, a recently conducted review has found that the therapeutic potential of these substances extends beyond mystical experiences.

The study authors argued that psychedelic benefits weren’t universal, noting that the drugs could also induce existential crises, anxiety and depersonalization. In their review, they highlight the importance of understanding these serious effects, particularly in a clinical context, because they may play a significant role in both the risks and benefits linked to psychedelic therapy.

The review also criticizes techniques used to measure the acute subjective effects of these substances, calling attention to the limitations and inconsistencies that impede clinical practice as well as research. Acute subjective effects include heightened affect, visual alterations, ineffability, emotional breakthrough and a sense of connectedness, among others.

Tools such as the 5D Altered States of Consciousness scale and the Mystical Experience Questionnaire have been used to evaluate these effects. Despite these tools being popular, the authors claim that they may not sufficiently forecast long-term therapeutic outcomes or even capture the entire range of experiences.

To make any advancements in this field, the authors demand that new and more comprehensive measures be developed which can accurately evaluate the diverse acute effects of psychedelics. This, they note, should include the creation of tools validated via strict empirical tests.

The authors’ findings have huge implications for the future of psychedelic therapy and research.

It is expected that scientists will be able to better understand how these substances affect the mind and how they contribute to mental health once the focus shifts from mystical experiences. This, in turn, may facilitate the development of efficacious therapeutic protocols that minimize the risks of these drugs while maximizing their benefits.

The need for empirically validated and data-driven measures becomes more important as scientific and public interest in psychedelics continues to increase. The review provides recommendations for clinicians and researchers alike, including suggestions on the development of next-gen psychometric tools and best practices for measuring acute subjective effects.

The review was authored by Roland R. Griffiths, Brandon Weiss, Sean P. Goldy and David B. Yaden. The researchers’ findings were published in “Nature Reviews Psychology.”

This study provides plenty of food for thought for the broader psychedelics industry, including companies such as Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ), to find more rigorous ways of measuring the effects of psychedelics on the mind. This is particularly critical given the recent rejection by the FDA of an MDMA drug with a recommendation that another phase 3 trial be done.

Mind Medicine Inc. (MNMD), closed Tuesday's trading session at $5.84, off by 2.8286%, on 619,387 volume. The average volume for the last 3 months is 88,000 and the stock's 52-week low/high is $2.41/$12.22.

The QualityStocks Company Corner

Nightfood Holdings Inc. (OTCQB: NGTF)

The QualityStocks Daily Newsletter would like to spotlight Nightfood Holdings Inc. (OTCQB: NGTF).

Nightfood Holdings (OTCQB: NGTF), a forward-thinking acquisition and development holding company, today announced the closing of its strategic all-stock acquisition of SWC Group Inc. (d/b/a CarryoutSupplies.com), a leading wholesaler and distributor of custom takeout packaging for the foodservice industry. The acquisition enhances Nightfood's operational efficiencies, expands its product offerings and customer base, and allows for synergistic growth opportunities. According to the announcement, the closing of the acquisition marks a pivotal moment in the company's growth and Nasdaq-uplist strategy.

"We are thrilled to announce the successful acquisition of CarryoutSupplies.com and excited for what we believe this acquisition will allow Nightfood to accomplish. This deal not only strengthens our position in the foodservice industry but also can drive immense value through operational efficiencies and the integration of complementary products and services across Nightfood's subsidiaries.," said Sonny Wang, Nightfood CEO.

To view the full press release, visit https://ibn.fm/NTmxz

Nightfood Holdings Inc. (OTCQB: NGTF) is a visionary holding company focused on identifying and capitalizing on explosive market trends within hospitality, food services and consumer packaged goods. By leading newly emerging categories and seizing opportunities in markets undergoing transformational upheaval, the company’s mission is to create unparalleled upside potential in industries ripe for innovation and growth.

Subsidiaries

Nightfood Inc.

The company’s flagship subsidiary, Nightfood Inc., is changing the way the world snacks at night. Humans are biologically hard-wired to crave sweets and fats at night – a survival mechanism from our hunter-gatherer days. Modern consumers know bingeing excess calories before the long nightly fast is no longer necessary for survival, but exploding screen time and decreased willpower at night results in over 90% of American adults snacking between dinner and bed every week, contributing to an estimated one billion nighttime snack occasions weekly (according to SleepFoundation.org).

The most popular choices – ice cream, cookies, chips and candy – are not only unhealthy but also impair sleep quality due to their nutritional profiles. Nightfood snacks are uniquely formulated by sleep and nutrition experts to satisfy nighttime cravings AND support better sleep.

Market Opportunity

Euromonitor International projects the American snack market will grow from $150 billion in 2022 to $170 billion in 2027. Snacking between dinner and bed is estimated to account for over $60 billion annually, creating an opportunity for a multi-billion-dollar sub-category to emerge in the coming years: sleep-friendly snacking.

Nightfood is the brand pioneering that category.

Nightfood’s innovation has led to partnership overtures from global giants, including the largest food and beverage company in the world, Nestlé, with whom Nightfood completed a “test-and-learn” joint initiative in 2023.

Management believes that successfully scaling Nightfood’s 2024 direct-to-consumer launch of sleep-friendly cookies will bring the category to life, opening the door for partnerships with and potential acquisition by global snack giants seeking to lead this potential billion-dollar emerging sub-category.

Future Hospitality Ventures Holdings Inc. (d/b/a roboOp365)

Future Hospitality Ventures Holdings, operating under the brand roboOp365, is revolutionizing the hospitality industry with cutting-edge automation and robotic solutions.

roboOp365 enhances operational efficiency and guest experiences through innovative technologies, including automated culinary bot, server robots and AI-enhanced applications. roboOp365 helps hospitality providers reduce costs, streamline operations and deliver superior service by integrating these advancements.

Market Opportunity

The robots-as-a-service (RaaS) business model has gained significant traction, super-charged by the COVID-19 pandemic, which instantly catalyzed game-changing growth and application. According to Verified Market Research, the service robotics market is projected to reach $173.17 billion by 2030, growing at a compound annual growth rate (CAGR) of 21.25%. Compared to Asia, the United States market is in the early stages of adopting these technologies, but acceptance is accelerating aggressively.

Several factors are driving this trend. Key industries such as hotels and restaurants are still struggling to rebound from the pandemic’s impact, hoping to return to pre-pandemic levels, if possible. Such recovery will largely be dependent upon service robots. In California specifically, factors such as rising labor costs, more rigorous labor laws and ongoing high turnover rates in labor-intensive sectors make it impossible for businesses to survive, thrive and compete without robotics.

Innovation Across Sectors

Nightfood Holdings Inc. is dedicated to driving innovation across its focus sectors of food services, automation and hospitality applications. In food services, the company leverages automation technology to drive operational efficiency for operators while meeting evolving consumer needs. In the hospitality industry, it’s deploying solutions that redefine guest experiences. Nightfood’s consumer-packaged goods initiatives are key to breakthrough trends in health and wellness.

Synergizing Food and Technology

The synergy of food and technology within Nightfood Holdings Inc. creates a holistic approach to innovation and automation. By integrating these areas, the company offers comprehensive solutions that address multiple facets of market needs. Its automation and artificial intelligence solutions in food service and hospitality create a seamless and enhanced consumer experience.

Through this integrated approach, Nightfood Holdings Inc. not only meets current market demands but also anticipates and influences future trends, positioning itself as a leader in innovation across these interconnected sectors. Synergies in these related and explosive categories result in operational efficiency and benefits for the company’s customers and partners and outsized upside and opportunity for its investors.

Management Team

Sean Folkson is the Chairman and President of Nightfood. He founded Nightfood when he couldn’t find a solution to his nighttime snacking problem. Recognizing the growing body of research linking nutritional intake with sleep quality, he launched the first snack brand specifically formulated to give consumers better, healthier and more sleep-friendly snacks for that peak-cravings slot between dinner and bed. He is a serial entrepreneur and problem-solver, having previously founded Specialty Equipment Direct, an online distributor of floor removal equipment, and AffiliatePros.com, a pioneering company in online affiliate marketing.

Lei Sonny Wang is the CEO of Nightfood Holdings. He is a strategist and business driver for early-stage and growth-stage companies. He is the founder and former CEO of Future Hospitality Ventures Holdings Inc., which was acquired by Nightfood Holdings Inc. At Future Hospitality, he leveraged his significant international business development experience into distribution relationships with leading global robotics manufacturers. At Nightfood, he is working to grow revenue and improve performance and profitability across all subsidiaries.

Nightfood Holdings Inc. (OTCQB: NGTF), closed Tuesday's trading session at $0.01831, up 7.2328%, on 23,629 volume. The average volume for the last 3 months is 9,596 and the stock's 52-week low/high is $0.0075/$0.0425.

Recent News

Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF)

The QualityStocks Daily Newsletter would like to spotlight Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF).

Exploration is an important step in finding minerals so they can be potentially mined.

Renforth Resources is actively involved in gold and mineral exploration through several Canada-based projects.

An update regarding the company's Malartic Metals Package Project includes a report on the mapping and prospecting work done at the project.

Minerals are key elements of daily life, and the exploration and supply of minerals are essential. Renforth Resources (CSE: RFR) (OTCQB: RFHRF) is an active mineral exploration company engaged in the exploration and development of its wholly owned, multicommodity mineral properties, which are located in Canada.

Annovis Bio Inc. Overview

Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) is an active mineral exploration company engaged in the exploration and development of the company’s wholly owned multi-commodity mineral properties in Canada. The company owns the Parbec gold deposit on the Cadillac Break in Quebec and is currently exploring the Parbec property to increase the gold resource and identify a location to strip and bulk sample from surface.

In addition, the company holds the Nixon Bartleman gold property in Ontario and is also engaged in developing its wholly owned Malartic Metals Package, Quebec’s newest polymetallic battery minerals district with several areas of mineralization, one of which is the nickel, cobalt, copper and zinc mineralized Victoria structure boasting approximately 20 kilometers of strike with surface mineralization, limited drilling, road access and hydroelectric power.

Renforth is well positioned in the heart of the Abitibi Greenstone belt, which straddles the Canadian Provinces of Ontario and Quebec, on both of the Cadillac-Larder Lake and Destor-Porcupine faults – the two main structures responsible for a belt endowed with more than 300 million ounces of gold (including production, M&I reserves and resources to date), making it one of the world’s most prospective gold regions.

The Canadian Malartic Mine, one of Canada’s largest gold mines, is adjacent to each of Renforth’s brownfield Malartic area properties, the Parbec open pit gold resource and the Malartic Metals Package, which, in addition to several known battery metals mineralized structures, also hosts gold within the Pontiac sediments, a very under-explored geological setting.

The company is headquartered in Pickering, Ontario.

Projects

Parbec Gold Deposit

Renforth’s 100% owned Parbec Gold Deposit contains a gold resource designed with an open pit to capitalize on Parbec’s surface mineralization. An MRE on the project, effective December 2019 and now considered by Renforth to be obsolete, is based upon approximately 28,000 meters of drilling which occurred between 2007 and 2019.

Renforth drilled 15,000 meters of new holes in 2020 and 2021 which were not included in the MRE, but which did extend the mineralization deeper within the MRE. The 2020-21 drilling is considered to have validated an additional 13,000 meters of historic drilling from 1986-93.

The validation occurs as 10% of the historic holes were redrilled, with results comparable to the historic results in terms of geology and gold values. Any future MRE calculated at Parbec will benefit from the inclusion of the new and historic drilling.

In addition to this, Renforth’s current structural interpretation on the location of, and controls on, the gold mineralization at Parbec is materially different than the geological model for the outdated MRE. For the first time, Renforth has mapped the Pontiac contact and interpreted a hinge fold interacting with the Cadillac Break and allowing the movement of gold enriched fluids, with mineralization plunging to the south, into the Pontiac.

It is worth noting that a structural control on the adjacent, and much larger, Canadian Malartic Mine is the Sladen Fault transiting into the Pontiac. Currently, Renforth is testing this interpretation with a soil survey designed to outline an area for stripping and bulk sampling within the Pontiac south of the Cadillac Break.

Malartic Metals Package

Renforth’s wholly owned approximately 300-square-kilometer Malartic Metals Package in Quebec’s mining heartland includes surface mineralization of battery metals nickel, cobalt, copper, zinc and silver in separate structures, as well as a copper/silver discovery and gold mineralization. Lithium is also present in anomalous amounts in the sediments, though the source has not yet been located.

The property was assembled commencing in 2020 by adding claims to Renforth’s existing Malartic West property by map staking. The goal was to acquire historic gold and base metal showings, as well as pronounced magnetic anomalies, joining several of the areas of discrete historic exploration into a district scale property with several areas of interest for battery metals and a greenfield copper/silver discovery. The property benefits from its location in an established mining community, roads on the property, rail just off the property and hydroelectric power lines crossing the property, making logistics simple and the cost to operate quite low.

This is the first time this property has been assembled as it is today and actively explored. A significant portion of the property has never been explored.

Market Overview

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, is worth nearly $5 trillion. The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth.

This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council. In August 2024, the market price of gold was approximately $2,435 per ounce.

Management Team

Nicole Brewster is President and CEO of Renforth Resources. During her tenure she has reconstituted the company, developed a maiden mineral resource and sold a gold deposit. She is a native of the Toronto area and has been around the mining business nearly all her life, having been raised by a successful mineral exploration geologist who worked (and is still working) around the world as an entrepreneur and geoscientist.

Ms. Brewster worked summer jobs in various segments of the mining business, which led to her employment as a contractor working in the early days of the digitization of exploration data, 3D modeling and data visualization. After working in the capital markets for a time, she returned to the mineral exploration business as a partner in a successful private firm with several employees.

Renforth Resources Inc. (OTCQB: RFHRF), closed Tuesday's trading session at $0.012, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0425/$.

Recent News

Horizon Fintex | Upstream

The QualityStocks Daily Newsletter would like to spotlight Horizon Fintex | Upstream

The gaming landscape is rapidly evolving, shaking up the digital landscape. This evolution is thanks to Web3 technology. Unlike traditional games, which rely on centralized platforms such as Steam, PlayStation and mobile app stores, Web3 games integrate blockchain technology, decentralized networks and tokenized economies. They determine how games are developed, distributed and played. But how does this shift affect the current Web3 gaming distribution? Before Web3, the gaming space was dominated by major platforms, such as Xbox, that served as centralized hubs where gamers could easily discover and download their favorite titles. Even though they are convenient for players, the hubs maintain control over game availability, pricing and—more importantly—player ownership of assets. As Web3 technology becomes more integrated and seamless, players will easily access and enjoy these games without even realizing they're using the technology. The idea of players owning their in-game assets and transferring them between different games is revolutionary. What's more, as regulatory clarity improves and onboarding becomes simpler, Web3 games could go mainstream. Platforms such as Gala Games and Hyperplay will continue to grow, and game fanatics could see traditional gaming giants, including Ubisoft and PlayStation, adopting blockchain technology in the near future. As the influence of Web3 on gaming deepens, we are also witnessing this technology making inroads into other industries, such as finance, as exemplified by the ways in which companies such as Horizon Fintex have incorporated Web3 functionalities in their systems.

Horizon Fintex is a software business specializing in compliant securities solutions. The company aims to facilitate the future of capital markets by leveraging the regulatory experience of Wall Street bankers and the proven track record of technology veterans to bring focus to compliance, efficiency, security and transparency.

Horizon’s flagship product is the revolutionary trading app ‘Upstream’, a MERJ Exchange Market, and the first regulated market powered by a blockchain to offer both digital securities and NFT trading. Upstream traders experience T+0 settlement, best bids and offers displayed on a transparent public orderbook that prevents predatory market practices – all from a user-friendly trading app.

Products

Horizon Fintex offers a full suite of end-to-end blockchain-enhanced software solutions to create a seamless experience for both issuers and investors. Its product suite includes:

  • Securitization & IssuanceETSware is an end-to-end Electronic Trading System streamlining capital raising from primary issuance through compliant secondary trading.
  • KYC Compliance OnboardingKYCware is a white label Know Your Customer (KYC) and Anti-Money Laundering (AML) compliance software solution offering best-in-class cryptographic security to compliantly onboard and verify user identity through a smartphone application.
  • AML Screening SoftwareAMLCop offers advanced Anti-Money Laundering (AML) software to streamline the verification of user details against a proprietary database of global sanctions, politically exposed persons (PEPs) and watchlists.
  • Cap. Table Management ToolsCustodyWare equips registered U.S. transfer agents with next-generation cap. table management software to manage securities on behalf of their clients pursuant to an SEC-registered or exempt securities offering.
  • Exchange & Trading App TechnologyOpen Order Book offers Ethereum blockchain securities exchange software to power the next generation of trading venues for digital assets.

Upstream – The Horizon-Powered Trading App

Upstream is a joint venture with MERJ Exchange (merj.exchange), an affiliate of the World Federation of Exchanges.

Upstream aims to be the premiere global trading hub offering issuers around the world exposure to a digital-first investor base that can trade using USDC digital currency along with credit, debit, PayPal, and USD (fiat) to increase liquidity and enhance price discovery; while also offering investors access to dual-listed companies, IPOs, crowdfunded companies, U.S. & Int’l. equities, digital coupons and NFTs directly from a user-friendly trading app.

Upstream aims to unlock liquidity for investors of all levels while offering industry-leading levels of transparency, accessibility and investor protections enforced using Ethereum blockchain technology.

Management Team

Brian Collins is the CEO of Horizon Fintex. He founded the company in 2010. From 1999-2010, Mr. Collins was CEO of Abbey Technology in Switzerland, specializing in the design of trading software for Swiss banks. Prior to this, he worked for Credit Suisse in Zürich, designing and building proprietary equity trading solutions. Mr. Collins graduated in 1990 with a BS in Computer Systems from the University of Limerick, Ireland.

Mark Elenowitz is the company’s President. He is a Wall Street veteran with over 29 years of experience. Mr. Elenowitz was the co-founder of a U.S. broker dealer and is Managing Director of two U.S. broker dealers, responsible for advising clients on compliance, capital structure and capital market navigation. He was responsible for leading the first successful Reg A+ IPO of a company to list on the NYSE and others which listed directly onto Nasdaq. He is a noted speaker at Small Cap and Reg A events, including the SEC Small Business Forum, and has been profiled in BusinessWeek and CNBC, as well as several other publications. Mr. Elenowitz is a graduate of the University of Maryland School of Business and Management with a BS in Finance and holds Series 24, 62, 63, 79, 82 and 99 licenses.

Dr. Andrew Le Gear is the CTO of Horizon Fintex. Prior to joining the company in 2013, he worked as a software engineer with Dell Inc. (2012-2013) and Lehman Brothers and Nomura Plc. (2007-2012). Dr. Le Gear was a co-founder of Juneberi Ltd., a research-driven software tech start-up (2004-2007). He graduated in 2006 with a Ph.D. in Computer Science from the University of Limerick, Ireland.

Peter Hall is the company’s CIO. Prior to joining Horizon Fintex in 2011, he worked at Microsoft (2008-2011), Atos Origin (2004-2008) and AIT Group Plc. (1998-2002). Mr. Hall has held CISSP certification since 2010. He graduated from the University of Sheffield, UK in 1995 and earned an MS from the University College London in 2006.

Mike Boswell is the CFO of Horizon Fintex. A Wall Street veteran, he co-founded a U.S. broker dealer and served as Chief Compliance Officer. Mr. Boswell was also Managing Director of TriPoint Capital Advisors, a merchant banking and financial consulting company, and CFO of Mission Solutions Group, a privately held defense sector firm. He earned an MBA from John Hopkins University and a BS in Mechanical Engineering from the University of Maryland. Mr. Boswell holds Series 24, 62, 63, 79, 82 and 99 licenses.

Recent News

chart

HeartBeam Inc. (NASDAQ: BEAT)

The QualityStocks Daily Newsletter would like to spotlight HeartBeam Inc. (NASDAQ: BEAT) .

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has named a seasoned medtech leader as its new chief financial officer. According to the announcement, Timothy Cruickshank has accepted the role of chief financial officer, effective immediately; he succeeds Richard Brounstein, who announced his retirement. Cruickshank has a proven track record of strategic planning, financial stewardship and commercial success with a focus on growing businesses with disruptive technologies through authentic leadership, strategic focus, data-driven decisions, and strong risk management and governance.

"Tim has an outstanding record of delivering results and creating value and will be a strong partner in ensuring we have a solid financial position as we strive to make our vision to transform the monitoring and detection of cardiac conditions a reality," said HeartBeam CEP and founder Branislav Vajdic, PhD, in the press release. "We thank Rick for his leadership over the past 9 years as he worked tirelessly to establish the strong financial foundation for the company which will continue to serve us well moving forward."

To view the full press release, visit https://ibn.fm/TbGyS

HeartBeam Inc. (NASDAQ: BEAT) is a cardiac technology company that has developed the first and only 3D-vector 12-lead electrocardiogram (ECG) platform for heart attack detection anytime, anywhere. The company’s proprietary ECG telehealth technology aims to redefine the way high risk cardiovascular patients are diagnosed in ambulatory and acute care settings. HeartBeam’s initial focus is on providing diagnostic data to help physicians with care management of patients with cardiovascular disease.

In August 2022, HeartBeam announced that it submitted its HeartBeam AIMI™ software for approval from the U.S. Food and Drug Administration (FDA). HeartBeam AIMI is a platform technology to improve the speed and accuracy of heart attack detection in acute care settings. The company expects FDA approval by the end of 2022, and a full commercial roll-out of HeartBeam AIMI is targeted for Q1 2023.

HeartBeam sees submission of its first product based on its platform technology as an important milestone toward commercialization, which underscores the company’s continued progress toward making the HeartBeam AIMI platform widely available to help emergency department physicians quickly and accurately identify a heart attack.

While the FDA conducts its regulatory review, HeartBeam will focus on executing key components of its commercialization plan and subscription revenue model. It will also continue to engage in discussions with strategic institutions, including academic centers, regional healthcare systems and regional community hospital systems that can utilize HeartBeam products.

The company is based in Santa Clara, California.

Products

HeartBeam’s development portfolio includes two products:

  • HeartBeam AIMI is software that provides a 3D comparison of baseline and symptomatic 12-lead ECG to more accurately identify a heart attack in acute care settings and, as noted above, has been submitted for FDA approval; and
  • HeartBeam AIMIGo™, the first and only credit card-sized 12-lead output ECG device coupled with a smartphone app and cloud-based diagnostic software system for remote heart attack detection.

HeartBeam is developing AIMIGo, a medical-grade detection and monitoring technology for use in remote heart attack detection, thereby allowing physicians to diagnose a patient’s heart attack as it occurs, even if the patient is not at a medical facility. The company’s system, once approved by the FDA, can be used by patients at home or almost anywhere and anytime to help their physicians assess whether chest pain is the result of a heart attack or another cause. While approximately 82% of chest pain ED visits are unnecessary, patients delay approximately 3 to 4 hours after symptoms begin, increasing mortality rates by 40%. The company’s goal is to shorten the time to treatment outside of the medical facility to improve patients’ well-being.

HeartBeam’s AIMIGo is a powerful, portable and easy-to-use prescription-based product. It comprises a smartphone app, a credit card-sized ECG device placed on a patient’s chest, the HeartBeam cloud platform, and a digital portal for the physician to view ECG results and direct patient action. For the first time outside of a medical setting, HeartBeam AIMIGo enables patients and their clinicians to determine if symptoms are due to a heart attack, quickly and easily, so care can be expedited, if needed.

Pending FDA clearance, AIMIGo is initially intended to be available by prescription, and is reimbursable under existing remote patient monitoring codes (RPM codes). This provides a new revenue stream to physicians who before did not have a way to monitor these high-risk patients. The RPM codes provide a monthly reoccurring revenue stream to the company, as well. On average, at current reimbursement rates, the practice will receive $1,300+ per year per patient they monitor, and the company will receive $600 per year per patient from this RPM reimbursement.

Market Overview

Adoption rates of telehealth services increased dramatically in recent years, with the COVID-19 pandemic serving as a major driver of growth. Among the areas seeing the greatest expansion are cardiology, radiology, behavioral health and online consultation.

Encouraging this growth, governments are actively developing new policies and reimbursement guidelines to promote the use of digital health platforms. The U.S. Centers for Medicare & Medicaid Services (CMS), for example, has recently expanded reimbursement for telehealth services. U.S. market growth is also being driven by the rising prevalence of chronic conditions and the growing geriatric population.

Remote heart attack detection is a previously unsolved problem with a massive and underserved market that is several times larger than the $2 billion total addressable market (TAM) in the U.S. for ECG cardiac arrhythmia monitoring.

Approximately 8 million Americans have suffered at least one heart attack, and a total of 18 million have been diagnosed with coronary artery disease (CAD). Based on these figures, HeartBeam projects a total addressable U.S. market TAM valued at $10 billion annually for its AIMIGo solution for remote heart attack monitoring of CAD.

Management Team

Branislav Vajdic, Ph.D., Chief Executive Officer and Founder of HeartBeam, Inc, combines over 30 years of experience in technology development and senior management positions. Dr. Vajdic has been deeply involved with the development of HeartBeam’s technology to fit his vision for the company. Prior to HeartBeam, from 2007 to 2010, Dr. Vajdic was CEO and Founder of NewCardio, a publicly traded company in the cardiovascular devices space. From 1984 to 2007, Dr. Vajdic was at Intel, where he held various senior management position. At Intel, Dr. Vajdic was the designer of first Flash memory and two key inventions that enabled Flash as a product and led engineering groups responsible for Pentium 1 through Pentium 4 designs. Dr. Vajdic was awarded two Intel Achievement Awards, the highest level of award for outstanding contributions to Intel. Dr. Vajdic is author of numerous patents and publications in the fields of cardiovascular devices, as well as chip design. Dr. Vajdic holds a Ph.D. in Electrical Engineering from the University of Minnesota.

Jon Hunt, Ph.D., has over 35 years’ experience in the medical/medical device industry with extensive domestic and international experience in general management, clinical/regulatory, sales and marketing. He also has diverse experience in Fortune 500 companies, as well as start-up environments. Dr. Hunt was the Vice President of Clinical Science and Technology, Medical Device Innovation Consortium, from July 2019 to July 2021, and Vice President of Clinical and Regulatory Affairs, Cryterion Medical from January 2018 to June 2019 (acquired by Boston Scientific Corporation in July 2018 for $202M). Dr. Hunt was the Founding President and CEO of Bardy Diagnostics, Inc. from October 2013 to November 2017 (acquired by Hill-Rom Holdings, Inc.). Prior to joining Bardy Diagnostics, Dr. Hunt spent the previous 11 years as the Vice President of Clinical & Regulatory Affairs with Cameron Health, Inc. (acquired by Boston Scientific Corporation). Dr. Hunt spent the previous 10 years with Cardiac Pacemakers, Inc., St. Jude Medical and Cardiac Pathways Corporation. Dr. Hunt began his career with Cardiac Pacemakers, Inc. (now Boston Scientific Corporation) as the Director of Clinical Programs. He subsequently held positions at St. Jude Medical in Clinical Affairs and as the Business Unit Director for the Cardiac Rhythm Management division for Europe, the Middle East and Africa. At Cardiac Pathways Corporation, Dr. Hunt held various executive positions as Vice President of International Sales and Marketing and Vice President of Worldwide Sales and Marketing (acquired by Boston Scientific Corporation). Dr. Hunt received his Ph.D. in Motor Control from The Pennsylvania State University, his Master’s from California State University, Long Beach and his undergraduate degree from Keele University in the United Kingdom.

Rick Brounstein, HeartBeam’s Chief Financial Officer, combines over 30 years of experience in health technology senior management. Since 2017, Mr. Brounstein has been and is currently a partner of Hardesty, LLC, a financial services firm, and Mr. Brounstein is currently a managing director of CTRLCFO, LLC, a firm Mr. Brounstein founded in 2016 to support funded start-ups in life science and technology. From 2008 to 2011, Mr. Brounstein was Chief Financial Officer of NewCardio, Inc., a microcap public company in the cardiology space, and, over his career, he has been with nine other companies in life science or technology, holding positions including Chief Financial Officer, Chief Operating Officer, Treasurer and Accounting Manager. From June 2001 through November 2007, Mr. Brounstein held several positions at Calypte Biomedical Corporation, a publicly traded medical device company, including Chief Financial Officer and Executive Vice President. In January 2007, Mr. Brounstein was appointed as the National Member Representative for the 2007 COSO Monitoring Project, which published new guidelines for monitoring internal financial controls in February 2009; Mr. Brounstein subsequently was a member of the FEI task force that issued the updated COSO Internal Control Framework in 2013. In March 2005, Mr. Brounstein was appointed to the SEC Advisory Committee on Smaller Public Companies. Mr. Brounstein earned his Certified Public Accountant (CPA) certification while working at Arthur Andersen LLP, formerly a public accounting firm. Mr. Brounstein holds a B.A. in accounting and an M.B.A. in finance, both from Michigan State University.

Ken Persen, HeartBeam’s Chief Technology Officer, combines over 28 years of experience in the medical device and digital health industries in engineering and senior management positions. Mr. Persen has been involved in several companies in Cardiac Rhythm Management, holding positions including Chief Executive Officer, Chief Technology Officer, Executive Vice President and Director of Engineering. Since 2016 and prior to joining HeartBeam, Mr. Persen was the Chief Technology Officer at LIVMOR, Inc., a digital health company. In addition, from 2016 through November 2021, he was also Chief Executive Officer of LIVMOR. Prior roles included Director of Engineering at Cameron Health (acquired by Boston Scientific), a late-stage medical device start up, and engineering and management positions at Guidant Corp. (acquired by Boston Scientific), a large medical device manufacturer. He has an undergraduate degree from University of Minnesota, Duluth, with a BA in Computer Science.

HeartBeam Inc. (NASDAQ: BEAT), closed Tuesday's trading session at $2.27, off by 3.4043%, on 62,091 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.06/$3.3893.

Recent News

Software Effective Solutions Corp. (OTC: SFWJ)

The QualityStocks Daily Newsletter would like to spotlight Software Effective Solutions Corp. (OTC: SFWJ).

Earlier this week, Volkswagen announced that it would be working with Revoltech GmbH to produce a leather alternative for its vehicles. Revoltech manufactures leather from hemp, making its products 100% plant-based, as well as plastic free and sustainable. The German automobile manufacturer made this announcement just months after the cannabis legalization law took effect in Germany. The industrial hemp to be used will be sourced from farms in the region, with Volkswagen noting that the material will be made from hemp residues that cultivators have no use for. In other news, the latest farm bill also contains provisions to lessen regulatory barriers for hemp cultivators and scale back a ban that prevented individuals with drug felony convictions from participating in the industry. Specifically, the legislation would allow the USDA as well as tribal entities and states to remove a policy that prohibits individuals with convictions in the past decade from obtaining licenses to produce industrial hemp. This new use case for hemp creates another money maker for the solid matter left after various entities, such as Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ), have extracted the compounds that they need from hemp biomass.

Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) is a global infrastructure and holding company in the cannabis industry. MedCana currently has five companies focused on pharmaceutical cannabis production, as well a software company focused on managing processes for plant-to-patient operations. The recent acquisition of an irrigation and greenhouse technology company has rounded out MedCana’s portfolio of holdings.

MedCana’s focus is on developing clients and companies in Latin America, initially in Colombia, and partnerships with laboratories, research facilities and hospitals throughout the world. MedCana is building the technology, laboratories, growing facilities and scientific teams to provide premium pharmaceutical-grade cannabis extracts to the world.

MedCana’s goal is to be the world’s premier resource for pharmaceutical cannabis products. The company believes its advantage is its global view and reach. From initial cultivation to final product, MedCana aims to help partners produce pharmaceutical CBD and other extracts that will have no equal.

The company’s mission is to utilize its technology to partner with and develop companies that provide premium pharmaceutical-grade cannabis extracts with absolute integrity, sustainability and social responsibility. MedCana’s team of pharmaceutical scientists includes some of the most respected chemists in the world. They aim to ensure that the company’s customers and partners create premium cannabis extracts that meet the growing worldwide demand. MedCana’s software is designed to ensure traceability and quality from seed to finished product.

MedCana is headquartered in Austin, Texas, with offices in Colombia.

Production

MedCana announced in May 2023 the beginning of full-scale production of non-THC cannabis for export to Europe in response to high demand in that market. This expansion comes after the successful completion of full crop cycle testing and infrastructure development at production sites in Columbia.

The recent acquisition of the assets of Tokan Corp., a software company focused on creating an enterprise resource planning (ERP) platform for the cannabis industry, and Eko2O S.A.S., a greenhouse and irrigation engineering company, has positioned MedCana for explosive growth in the region.

As a MedCana subsidiary, Eko2O SA will increase the company’s revenue potential in Central and South America. The subsidiary specializes in the construction and distribution of greenhouses and sophisticated irrigation platforms. A positive outlook has resulted from the company’s expansion as it investigates new opportunities for greenhouse and irrigation system installations in Panama and Uruguay. These opportunities are expected to accelerate Eko2O’s development and strengthen its position as a top supplier of innovative agricultural solutions in cannabis and other sectors that are quickly moving to high technology agricultural production.

In addition, MedCana has started talks with the government in Argentina about possible incentives for beginning operations in that country as part of its ongoing worldwide development strategy. Support from the Argentinean government and the start of new operations there would greatly increase MedCana’s market share in Latin America and solidify the company’s position as the market leader in the cannabis industry.

Market Opportunity

According to a report by Grand View Research, a San Francisco-based market research and consulting company, the global cannabis extract market was valued at $3.5 billion in 2022 and is expected to expand at a CAGR of 20% from 2023 to 2030 to be worth more than $15 billion.

Growing demand for cannabis extracts, including oils and tinctures, and the increased legalization of marijuana for the treatment of different chronic ailments like arthritis, Alzheimer’s, anxiety and cancer are driving the expansion of the industry. The marijuana derivative industry is flourishing due to a greater understanding of its various medical benefits.

Management Team

Jose Gabriel Diaz is CEO of MedCana. He has successfully built, grown and sold multiple telecom companies. He was senior vice president of sales at IP Communications, a national high-speed data provider. He also founded Reallinx, a national data carrier later sold to GTT Communications. Additionally, he is currently president of the A.E.M. Business and Entrepreneurship Association in Austin, Texas.

Claudio Jiménez Cartagena, QF, Ph.D. is Chief Scientific Officer at MedCana. He joined MedCana after working with Sosteli Pharma as Technical Director and serving as a director consultant for the Corporation for Agricultural Industrial Development at the University of Antioquia in Colombia. Before that, he worked as the scientific director at the Institute of Food Science & Technology. He holds a bachelor’s degree in pharmaceutical chemistry, a master’s degree in basic biomedical sciences and a doctoral degree in Environmental Engineering from the University of Antioquia.

Julián Alberto Londoño Londoño, Ph.D., is Senior Vice President of Operations at MedCana. He previously served as general manager for the Corporation for Agricultural Industrial Development, and as Chief Scientific Officer at Sosteli Pharma in the Resource Management Department. He has developed multiple U.S. patents, and recently served as senior advisor to the Secretariat of Agriculture Development for the Government of Antioquia. He holds a doctorate in Chemical Sciences from the University of Antioquia.

Software Effective Solutions Corp. (OTC: SFWJ), closed Tuesday's trading session at $0.015, off by 11.7647%, on 7,150 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.000001/$0.09.

Recent News

D-Wave Quantum Inc. (NYSE: QBTS)

The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).

D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.

D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).

D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.

D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.

Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.

Advantage™ Quantum Computer

 

With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.

D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.

That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.

Leap Quantum Cloud Service

 

D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.

Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.

Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.

D-Wave Launch

D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.

From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.

Target Verticals

While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:

  • Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
  • Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
  • Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.

Market Opportunity

The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.

Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.

D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.

D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.

Leadership Team

Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.

John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.

D-Wave Quantum Inc. (NYSE: QBTS), closed Tuesday's trading session at $0.936, up 11.0452%, on 2,172,689 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.57/$2.44.

Recent News

Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF)

The QualityStocks Daily Newsletter would like to spotlight Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF).

Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF) is a mineral exploration company engaged in advancing precious and base metal deposits in the state of Arizona. Its flagship copper-gold-zinc-silver asset is the Kay Mine Project, located in Yavapai County. The company also owns Sugarloaf Peak gold project in La Paz County.

The company in October 2022 received permit approval from the Bureau of Land Management (BLM) for two new drill pads, located approximately 1,200 meters west of the Kay Mine Deposit. These new pads will allow for testing of the company’s Western Target, while also allowing for drilling of additional coincident anomalies located between the Central and Western Targets. Construction of the drill road for the Central Target (located 500 meters west of the Kay Mine Deposit) is currently underway, with drilling expected to begin in November 2022. Road construction for the Western Target will begin upon confirmation of BLM acceptance of the company’s posted bond, with drilling expected to commence in Q1 2023.

The company is fully funded, with $60 million in cash as of June 30, 2022, to complete the remaining 18,000 meters planned for the Phase 2 program at Kay, as well as an additional 76,000 meters in the Phase 3 program (budgeted at $27 million), which will be used to test the numerous parallel targets heading west of the Kay Deposit, as well as the northern and southern extensions of the Kay Deposit.

Arizona Metals Corp. is based in Toronto, Canada.

Projects

Arizona Metals Corp. owns 100% of the Kay Mine property in Yavapai County, which is located on a combination of patented and BLM claims totaling 1,300 acres that are not subject to any royalties. An historic estimate by Exxon Minerals in 1982 reported a “proven and probable reserve of 6.4 million short tons at a grade of 2.2% copper, 2.8 grams per ton gold, 3.03% zinc, and 55 grams per ton silver.” The historic estimate has not been verified as a current mineral resource. None of the key assumptions, parameters, and methods used to prepare the historic estimate were reported by Exxon, and no resource categories were used. Significant data compilation, re-drilling and data verification may be required by a “qualified person” (as defined in National Instrument 43-101 – Standards of Disclosure for Mineral Projects) before the historic estimate can be verified and upgraded to be a current mineral resource. A qualified person has not done sufficient work to classify it as a current mineral resource, and Arizona Metals is not treating the historic estimate as a current mineral resource.

The company also owns 100% of the Sugarloaf Peak Property in La Paz County, which is located on 4,400 acres of BLM claims. Sugarloaf is a heap-leach, open-pit target and has a historic estimate of “100 million tons containing 1.5 million ounces (of) gold” at a grade of 0.5 grams per ton. The historic estimate at the Sugarloaf Peak Property was reported by Westworld Resources in 1983. The historic estimate has not been verified as a current mineral resource. None of the key assumptions, parameters, and methods used to prepare the historic estimate were reported, and no resource categories were used. Significant data compilation, re-drilling and data verification may be required by a qualified person before the historic estimate can be verified and upgraded to a current mineral resource. A qualified person has not done sufficient work to classify it as a current mineral resource, and Arizona Metals is not treating the historic estimate as a current mineral resource.

Market Opportunity

The World Gold Council, an industry association representing gold producers with hundreds of mining operations in nearly 50 countries around the world, reports that global demand for gold during the first six months of 2022 was 2,189 tons, a 12% increase in demand over the same period in 2021. Demand came primarily from gold bar and coin investors, jewelry consumers, central bank purchases to bolster currency reserves and technology manufacturing.

The average price per ounce for the period was $1,871, marking a 1% year-over-year increase. The council reported gold mine production for the period was up 3% over 2021 at 1,764 tons. For the remainder of 2022 and into 2023, the council projects flat gold demand with possible slight increases in gold mine production. The council notes that unpredictable geopolitical factors, the Ukraine war for example, and likelihood of global economic slowdown could have significant near-term impact on gold demand and prices.

Management Team

Marc Pais is President and CEO of Arizona Metals. He previously founded and served as President of Telegraph Gold (listed as Castle Mountain Mining), which was acquired by Equinox Gold, a TSX-listed mining company. He has seven years of experience as a Mining Analyst, with a focus on precious metals development companies. He holds a B.Sc. in Geological Engineering (Mineral Exploration) from Queen’s University in Canada.

David Smith is the Vice President, Exploration of Arizona Metals. He has 30 years of global precious metals exploration experience, including codiscovery of the Solidaridad/La Sabila deposit in Mexico with deposits estimated at 1 million ounces of gold. His core areas of expertise are managing mineral projects from acquisition to exploration, resource modeling and mineral project development. He holds an M.Sc. from the University of Oregon and an MBA from Pinchot University/Presidio Graduate School.

Paul Reid is the Executive Chairman of Arizona Metals. He previously founded and served as Executive Chairman of Telegraph Gold (listed as Castle Mountain Mining), which was acquired by Equinox Gold, a TSX-listed mining company. Paul has extensive experience as an Investment Banking professional, involved in raising capital, go-public transactions, and advisory services.

Arizona Metals Corp. (OTCQX: AZMCF), closed Tuesday's trading session at $1.3765, up 7.5391%, on 409,597 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.21/$2.45.

Recent News

FingerMotion Inc. (NASDAQ: FNGR)

The QualityStocks Daily Newsletter would like to spotlight FingerMotion Inc. (NASDAQ: FNGR) .

FingerMotion Inc. (NASDAQ: FNGR) is an evolving technological company with core competencies in mobile payment and recharge platform solutions in China. FingerMotion is in the process of developing additional value-added technologies to market to users.

Founded in 2016, FingerMotion’s goal is to serve over a billion users in the Chinese market and expand its model to other regional markets. The company has offices in Hong Kong, Shanghai and New York City.

Current Offerings

FingerMotion is analyzing and transforming mobile data to improve the lifestyle of the public through technology and innovation. The company’s current offerings include:

  • Telecommunications Products and Services – FingerMotion’s proprietary universal exchange platform, ‘PigeonHole Integration System (PIS)’, offers seamless integration between telecom operators and online stores. The service platform’s offerings include top up and recharge, data plan, mobile phone, loyalty points redemption and subscription plans. The platform offers reliable and secure transactions, real-time reconciliation, simple integration for partners and efficient settlements.
  • SMS and MMS Services – The integrated platform is registered as FingerMotion’s IP in China and provides a robust back-end control panel for corporate partners to manage their own messaging settings. FingerMotion’s clients range from insurance to financial industries, ecommerce firms, airlines and more. The platform offers competitive pricing for partners and provides quick and efficient review to meet timely marketing initiatives.
  • Big Data Insights – FingerMotion brings Big Data-enabled insurance solutions through its Big Data Insights arm, Sapientus. The company’s strategic partnerships with the largest Chinese telecommunications giants allow access to uncover behavior insights through geolocation and mobile data usage. Its Big Data offerings include risk scoring, precise marketing, simplified underwriting and customized products.
  • Rich Communication Services (RCS) – FingerMotion’s RCS platform will be a proprietary business messaging solution that enables businesses and brands to communicate their services to customers via 5G infrastructure. The company expects its RCS platform to offer a better user experience, more efficiency and cost-effectiveness when compared to other solutions.

Telecommunications and Insurtech Markets

The global telecommunications market was valued at $1.74 trillion in 2019 and is expected to grow at a CAGR of 5% from 2020 to 2027. The steady increase is expected to be driven by the adoption of 5G and the increased popularity of Internet of Things (IoT) applications.

The Chinese telecom market was valued at $254.1 billion in 2017 and is also constantly expanding. The current Chinese telecom market is dominated by three mobile operators – China Mobile, China Unicom and China Telecom, which together are responsible for around 1.6 billion active subscribers (https://ibn.fm/zfwy9).

In addition, the insurtech (insurance technology) market was valued at $2.72 billion globally in 2020 and is expected to grow at a CAGR of 48.8% from 2021 to 2028. The large increase is attributed to the rising use of technology solutions for everyday activities like acquiring insurance coverage (https://ibn.fm/TGo7D).

Through its proprietary platforms and technologies, FingerMotion is uniquely positioned to capitalize on the telecom and insurtech markets’ growth and opportunities.

Management Team

Martin J. Shen is the Chief Executive Officer of FingerMotion Inc. He has over 15 years of experience in senior management roles within entrepreneurial startups and large multinational corporations. He has acquired a wide range of corporate management, financial oversight and operation administration expertise through these roles. In his most recent role, he founded Imperial Distributors (formerly known as AP Martin Pharmaceutical Supplies Ltd.), establishing the company as the preferred choice for distributional support to regional pharmacies throughout Western Canada. Before founding Imperial, Mr. Shen served as the Chief Operating Officer and Chief Financial Officer at Wales and Son Industrial (formerly Weir Minerals), a firm specializing in global delivery and support for mining slurry equipment. He began his career at PricewaterhouseCoopers in Vancouver, with work tours in the tax department in Singapore and the tax audit and advisory group in Hong Kong. Mr. Shen is a U.S. Certified Public Accountant and holds a Bachelor of Science from the University of British Columbia.

Lee Yew Hon is the company’s Chief Financial Officer. From 2006 until November 2020, he was the Chief Financial Officer of Cubinet Interactive Group of Companies, and he also took on the Chief Operating Officer role in 2011. During his tenure, he was instrumental in leading Cubinet and building teams across the Southeast Asia region, setting up financial processes within a short time. Mr. Lee spearheaded the growth of Cubinet to other regions, including Europe, the Middle East and Russia. He received his diploma from Tunku Abdul Rahman College in 1996. He is a Chartered Accountant, a member of the Malaysia Institute of Accountants (MIA) and an Associate Member of the Chartered Institute of Management Accountants, UK (ACMA).

Li Li is the Senior Vice President of FingerMotion. She recently served as Advisor to Shenzhen WuYiKa Technology Co. Ltd., a comprehensive service platform dedicated to online service distribution and payment. The company has become a fast and efficient provider of new media marketing solutions for the mobile internet. She has held high-level management positions with multiple industry names, including Hangzhou JiuYue Information Technology Co. Ltd. and Hangzhou LingXuan Information Technology. Ms. Li started her career in 2004, founding Shanghai ChuangYeZZ Network Technology Co. Ltd. and serving as its Vice President. With the close cooperation of local operators, the company launched SMS, MMS, WAP, mobile JAVA games, Hunan Satellite TV e-magazine and other wireless internet services to meet the rapid development of wireless internet and application requirements. She received her degree from Nanjing Academy of Engineering.

FingerMotion Inc. (FNGR), closed Tuesday's trading session at $2.15, up 6.4356%, on 126,756 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.63/$7.97.

Recent News

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI)

The QualityStocks Daily Newsletter would like to spotlight Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI).

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) is a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products primarily for the treatment of infectious diseases and autoimmune diseases.

In collaboration with the prestigious Max Planck Institute for Multidisciplinary Sciences (MPG) and the University Medical Center Göttingen (UMG), both in Germany, Scinai is developing a pipeline of innovative nanosized antibody (NanoAb) therapies addressing diseases underserved by current treatments and with large and growing markets, such as COVID-19, asthma and psoriasis.

NanoAbs, also known as VHH-antibodies or Nanobodies, are alpaca-derived nanosized antibodies that exhibit multiple significant competitive advantages over existing antibody therapies, including stability at high temperatures, superior binding affinity, more effective and convenient routes of administration and efficient production. Scinai is uniquely positioned to advance nanosized antibody innovation from R&D through commercialization.

The company’s highly experienced and successful pharmaceutical industry leadership team includes former senior executives from Novartis, GSK and Bristol-Myers Squibb.

Since its founding, Scinai has executed eight clinical trials, including a seven-country, 12,400-participant Phase 3 trial of a prior influenza vaccine candidate, and it built, owns and operates a 20,000 sq. ft. state-of-the-art GMP biologics manufacturing facility housing its laboratories, production facilities and offices.

Lead Candidate: Inhaled COVID-19 NanoAb

In December 2021, Scinai signed definitive agreements with the Max Planck Society – parent organization of the Max Planck Institute for Multidisciplinary Sciences– and the UMG to enter a strategic collaboration for the development and commercialization of innovative COVID-19 NanoAbs.

The company is planning a rapid development path that leverages its expertise and capabilities in biological drug development and manufacturing. Scinai anticipates preclinical proof-of-concept results for an inhaled COVID-19 NanoAb by the end of 2022, with initial Phase 1/2a human clinical trial results expected in 2023.

The intended inhaled mechanism of delivery of Scinai’s COVID-19 NanoAb formulation may serve as a significant differentiator when compared to approved monoclonal antibodies, which are injected. Inhaled delivery has shown to be cheaper, more convenient and likely safer for patients and providers.

NanoAb Pipeline: Psoriasis, Asthma and More

The COVID-19 NanoAb development agreement is part of a broader five-year research collaboration agreement signed in March 2022 covering discovery, development and commercialization of NanoAbs for several other disease indications with large market medical needs, including asthma, psoriasis, macular degeneration and psoriatic arthritis.

Scinai has an exclusive worldwide license for development and commercialization of COVID-19 NanoAbs and exclusive options for similar worldwide licenses for NanoAbs for the above mentioned additional large market disorders currently underserved by approved therapeutic antibodies.

Academic research teams from MPG and UMG have verified strong affinity by the new NanoAbs to their biological target molecules and high thermostability. They have also demonstrated strong neutralization by several NanoAb candidates of their respective target molecules. Neutralization studies of the other NanoAbs are expected to begin later in 2022.

Based on the promising results, Scinai will focus development efforts beginning with the following NanoAbs:

  • NanoAbs targeting IL-17 as drug candidates for the potential treatment of psoriasis and psoriatic arthritis
  • NanoAbs targeting IL-13 and NanoAbs targeting TSLP as drug candidates for the potential treatment of asthma

These are conditions for which the antibody target is validated by existing treatments and the mechanism of action is well understood. Both represent large medical needs and growing markets. Scinai anticipates preclinical proof-of-concept for at least one of these NanoAbs in 2023. This is in addition to the aforementioned human clinical Phase 1/2a for the inhaled COVID-19 NanoAb therapy, which is also anticipated in 2023.

CDMO Services

While NanoAb pipeline development is Scinai’s core focus, the company also offers its cGMP manufacturing facility, aseptic fill and finish suite, laboratories and experienced professionals for contract development and manufacturing organization (CDMO) services. This offering is designed to keep the Scinai team abreast of the latest industry developments and trends while building experience and generating revenue to support the company’s NanoAb pipeline development.

Market Opportunity

COVID-19 treatment, target of the company’s lead NanoAb therapy candidate, had an estimated market size of $22 billion in 2021.

Future Scinai drug candidates will target conditions with large markets growing at attractive CAGRs.

The global asthma treatment market was valued at $18.08 billion in 2019 and is projected to reach $26.01 billion by 2027, exhibiting a CAGR of 4.5% during the forecast period, according to Fortune Business Insights. The research firm predicts that the global psoriasis treatment market will grow from $26.37 billion in 2022 to $47.24 billion by 2029, exhibiting a CAGR of 8.7% over the forecast period.

Management Team

Amir Reichman is Scinai’s CEO. He previously was Head of Global Vaccines Engineering Core Technologies at GSK Vaccines in Belgium. Prior to that, he held leadership roles at Novartis Vaccines’ Global Vaccines Supply Chain Management organization. He was the first employee of NeuroDerm Ltd., a company focused on transdermal drug delivery, and served as Senior Scientist until his departure in 2009. He earned a M.Sc. in Biotechnology Engineering from Ben-Gurion University and an MBA in Finance and Health Care Management from the University of Pennsylvania’s Wharton School.

Tamar Ben-Yedidia, Ph.D., is Chief Science Officer at Scinai. She has more than 30 years of experience in immunology, with specific expertise in the development of vaccines. She began her career with Biotechnology General Ltd., working on development of a recombinant Hepatitis-B vaccine. She later joined the Weizmann Institute of Science, working on the design of a peptide-based vaccine against several pathogens. She is widely published, with numerous refereed articles and invited reviews in various scientific journals. She received her Ph.D. from the Weizmann Institute.

Elad Mark is COO at Scinai. He has over 15 years of biotechnology industry experience encompassing diverse project stages including feasibility studies, conceptual and detailed design, commissioning, qualification and process validation. Prior to joining Scinai, he led Novartis’s $800 million investment in a biologics facility in Singapore. With Biopharmax and Antero, both global pharmaceutical engineering companies, he successfully led projects in Israel, China and Singapore. He holds a BSc. in Engineering from the Afeka Tel Aviv Academic College of Engineering and an MBA from the Open University of Israel.

Uri Ben-Or is CFO at Scinai. He has served as CFO with public life science companies traded on the TASE, OTC and Nasdaq. Ben-Or provides his services to Scinai through CFO Direct, a company he founded and for which he serves as CEO. He served as the VP of Finance of Glycominds, a leading biotechnology company, and as CFO of a spin-off from Telrad Networks. He also served as a Corporate Controller at Menorah Capital Markets and as an Auditor at PWC. He holds a B.A. in Business from the College of Administration, an MBA from Bar-Ilan University, and is a CPA.

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), closed Tuesday's trading session at $3.5, up 5.1051%, on 7,192 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $2.23/$13.70.

Recent News

Lexaria Bioscience Corp. (NASDAQ: LEXX)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (NASDAQ: LEXX).

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator in drug delivery platforms. The company’s patented technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules. DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery and has been thoroughly evaluated through in vivo, in vitro and human clinical testing.

DehydraTECH is covered by 21 issued and more than 50 pending patents in over 40 countries around the world. Lexaria’s first patent was issued by the U.S. Patent and Trademark Office in October 2016 (US 9,474,725 B1), providing 20 years of patent protection expiring June 2034. Multiple patents have been awarded since then and are expected in the future.

Lexaria has also collaborated with the National Research Council (NRC), the Canadian government’s premier research and technology organization. The company has been granted patent protection for specific delivery of nicotine, vitamins, NSAIDs, antiviral drugs, cannabinoids and more.

Lexaria began developing DehydraTECH in 2014 and has since continued to strengthen and broaden the technology. The company has no plans to create or sell Lexaria-branded products containing controlled substances. Instead, Lexaria licenses its technology to other companies around the world to offer consumers the best possible performance across an array of ingestible product formats.

The company’s technology is best thought of as an additional layer that providers of consumer supplements, prescription and non-prescription drugs, nicotine and CBD products can utilize to improve the effectiveness of their own existing or planned new offerings. Lexaria has licensed DehydraTECH to multiple companies, including a world-leading tobacco producer for the research and development of smokeless, oral-based nicotine products, and for use in industries that produce cannabinoid beverages, edibles and oral products.

DehydraTECH is suitable for use with a wide range of product formats including pharmaceuticals, nutraceuticals, consumer packaged goods and over-the-counter capsules, pills, tablets and oral suspensions.

DehydraTECH Technology

Lexaria’s DehydraTECH is designed specifically for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. DehydraTECH increases their effectiveness and improves the way active pharmaceutical ingredients enter the bloodstream. The major benefits to a subject ingesting a DehydraTECH-enabled drug or consumer product can be summarized by the following:

  • Speeds up delivery – the effects of the product are felt by the subject in just minutes.
  • Increases bioavailability – the technology is much more effective at delivering a drug or product into the bloodstream.
  • Increases brain absorption – animal testing suggests significant improvement in the quantity of drug delivered across the blood-brain barrier.
  • Improves drug potency – more of the ingested product is made available to the body, so lower doses are required to achieve the desired effect.
  • Reduces drug administration cost – lower doses mean lower overall drug costs.
  • Masks unwanted taste – the technology eliminates or reduces the need for sweeteners.

Lexaria has demonstrated in animal studies a propensity for DehydraTECH technology to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,900 percent, initiating additional new patent applications and opening possibilities for improved drug delivery.

Since 2016, DehydraTECH has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to five to 10 times, reduce time of onset from one to two hours to just minutes, and mask unwanted tastes. The technology is to be further evaluated for additional orally administered bioactive molecules, including antivirals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) and nicotine.

Market Outlook

Lexaria’s ongoing research and development efforts are mainly focused on development of product candidates across several key segments:

  • Oral Cannabinoids – a market estimated to be worth $18.4 billion in 2021 and expected to reach $46.2 billion by 2025.
  • Antivirals – an estimated $52.1 billion market in 2021 that’s expected to grow to $66.7 billion by 2025.
  • Oral Mucosal Nicotine – smokeless tobacco products, a $13.6 billion market in 2018, is forecast to grow at 7.2 percent annually through 2025.
  • Human Hormones – estrogen and testosterone replacement therapies represented a $21.9 billion market in 2019, with a forecast CAGR of 7.7 percent through 2027.
  • Ibuprofen and Naproxen – NSAID sales totaled $15.6 billion globally in 2019 and are projected to reach $24.4 billion by 2027.
  • Vitamin D3 – the global market size was $1.1 billion in 2021, growing at 7 percent per year and expected to reach $1.7 billion in 2026.

Management Team

Chris Bunka is Chairman and CEO of Lexaria Bioscience Corp. He is a serial entrepreneur who has been involved in several private and public companies since the late 1980s. He has extensive experience in the capital markets, corporate governance, mergers and acquisitions, as well as corporate finance. He is named as an inventor on multiple patent innovations.

John Docherty, M.Sc., is the President of Lexaria. He is a pharmacologist and toxicologist, and a specialist in the development of drug delivery technologies. He is the former president and COO of Helix BioPharma Corp. (TSX: HBP). He is named as an inventor on multiple issued and pending patents.

Greg Downey is Lexaria’s CFO. He has more than 35 years of diverse financial experience in the mining, oil and gas, manufacturing, and construction industries, and in the public sector. He served for eight years as CFO for several public companies and has provided business advisory and financial accounting services to many large organizations.

Gregg Smith is a strategic advisor to Lexaria. He is a founder and private investor with Evolution VC Partners. He is a member of the Sand Hill Angels and held previous investment banking roles with Cowen and Company and Bank of America Merrill Lynch.

Dr. Philip Ainslie serves as a scientific and medical advisor to Lexaria. He is co-director for the Centre for Heart, Lung and Vascular Health, Canada. He is also Research Chair in Cerebrovascular Physiology and Professor at the School of Health and Exercise Sciences, Faculty of Health and Social Development at the University of British Columbia.

Lexaria Bioscience Corp. (LEXX), closed Tuesday's trading session at $3.55, up 4.7198%, on 84,800 volume. The average volume for the last 3 months is 188,103 and the stock's 52-week low/high is $0.85/$6.85.

Recent News

Wheaton Precious Metals Corp. (TSX: WPM) (NYSE: WPM)

The QualityStocks Daily Newsletter would like to spotlight Wheaton Precious Metals Corp. (TSX: WPM) (NYSE: WPM).

Wheaton Precious Metals Corp. (TSX: WPM) (NYSE: WPM) is one of the largest precious metals streaming companies in the world. It generates revenue primarily from the sale of precious metals and cobalt while offering investors cost predictability, direct leverage to increasing precious metals prices and a high-quality asset base.

Wheaton seeks to be the world’s premier precious metals investment vehicle, delivering value through streaming to all stakeholders. The company has entered into agreements to purchase all or a portion of the precious metals or cobalt production from high quality mines for an upfront payment and an additional payment upon delivery of the metal. By crystallizing value for precious metals yet to be produced, Wheaton works with its partners to unlock and create value.

Wheaton currently has streaming agreements for 18 operating mines and 27 development stage projects. The company’s production profile is driven by a portfolio of low cost, long-life assets, including a gold stream on Vale’s Salobo mine and a silver stream on Newmont’s Penasquito mine.

With its portfolio of long-life, low-cost assets, Wheaton’s business model offers investors exposure to commodity prices and exploration upside with a much lower risk profile than a traditional mining company. Wheaton delivers among the highest cash operating margins in the mining industry, allowing it to pay a competitive dividend and continue to grow through accretive acquisitions. As a result, Wheaton has consistently outperformed gold and silver, as well as other mining investments.

The company is headquartered in Vancouver, British Columbia. Wheaton is committed to strong ESG practices and giving back to the communities in which its mining partners operate.

Business Model

The company’s 18 operating mines and 27 development projects in North, Central and South America; Australia; Europe and Africa produce gold, silver, palladium, platinum and cobalt.

Wheaton’s streaming advantage comes from investing in high quality assets with predictable production costs. As of July 2024, 93% of Wheaton’s current production comes from high margin mines operating in the lower half of their respective cost curves.

The company has contractually defined cost-per-ounce production agreements protecting it from inflationary cost pressures. This cost predictability, with delivery payments per ounce predetermined, translates into direct exposure to potential increases in precious metal prices, providing investors with some of the highest sustainable margins in the industry.

The company has entered into precious metals purchase agreements with 32 different mining companies for the purchase of precious metals and cobalt relating to 18 operating mining assets, in addition to 23 at various stages of development and four that have been placed in care and maintenance or have been closed. These mining assets are located across 16 countries.

Wheaton acquires mine production from its partners generally at or below the prevailing market price. The primary drivers of the company’s financial results are the volume of metal production at the various mining assets to which the precious metal purchase agreements relate and the price realized by Wheaton upon sale of the metals it receives.

Wheaton is actively pursuing future growth opportunities, primarily by way of entering into additional precious metal purchase agreements.

Market Opportunity

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, is worth nearly $5 trillion. The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth.

This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council. In July 2024, the market price of gold was approximately $2,450 per ounce.

The Silver Institute, the association of the silver industry, reported in April 2024 that silver use in industrial applications set a new record high in 2023 at 654.4 million ounces (Moz). This figure excludes silver used in production of jewelry or in ornamental and decorative applications.

The institute reported that demand exceeded silver supply in 2023 for the third consecutive year, resulting in a structural market deficit of 184.3 Moz. Production of photovoltaic (solar energy) equipment is now the largest industrial use of the metal and is expected to continue its strong growth trend. In July 2024, the market price of silver was just over $29 per ounce.

Management Team

The company has an experienced management team with a strong track record of success and is well positioned for further growth.

Randy Smallwood is President and CEO of Wheaton Precious Metals and a Director. He previously served as the company’s Executive Vice President of Corporate Development. Prior to Wheaton Precious Metals, he was the Director of Project Development at Wheaton River Minerals Ltd. He formerly served on the boards of several resource companies including Defiance Silver, Ventana Gold, Castle Peak Resources and Tigray Resources. He holds a geological engineering degree from the University of British Columbia and a mine engineering diploma from the British Columbia Institute of Technology.

Gary Brown is Senior Vice-President and CFO of Wheaton Precious Metals. He previously was CFO of TIR Systems Ltd. and has also held senior finance roles with CAE Inc., Westcoast Energy Inc. and Creo Inc. He has more than 30 years of experience in finance and holds professional designations as a Chartered Professional Accountant and a Chartered Financial Analyst. He earned a master’s degree in accounting from the University of Waterloo.

Haytham Hodaly is Senior Vice-President of Corporate Development of Wheaton Precious Metals. He previously spent more than 16 years in the North American securities industry. Prior to that, he held the position of co-director of research and senior mining analyst at Salman Partners Inc. He is an engineer with a bachelor’s degree of applied science in mining and mineral processing engineering and a Master of Engineering, specializing in mineral economics, both from the University of British Columbia.

Wheaton Precious Metals Corp. (NYSE: WPM), closed Tuesday's trading session at $59.41, up 1.4515%, on 1,155,818 volume. The average volume for the last 3 months is 1.417M and the stock's 52-week low/high is $38.3738/$63.06.

Recent News

NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW)

The QualityStocks Daily Newsletter would like to spotlight NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW).

NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW), a next generation e-commerce platform, was created with vision and purpose to capitalize on high growth sectors and global markets. The company collaborates with businesses – large and small – to simplify and accelerate online commerce and uniquely enables customers and partners to optimize their e-commerce reach, presence and revenue. NextPlat recently launched a new e-commerce development program to provide American businesses with easy access to the massive Chinese consumer market.

Current Initiatives

NextPlat provides cutting edge technology in an advanced e-commerce ecosystem. The company is actively expanding its global network of online storefronts serving thousands of consumers, enterprises and governments. The company also has developed a next generation platform built for Web3 that enables the creation and sale of digital assets, as well as optimizing e-commerce transactions and business building activities. The company’s current initiatives include:

  • E-Commerce Development Program – In April 2023, NextPlat announced it had entered into a merchant sourcing agreement with Alibaba.com Singapore E-Commerce Private Limited (“Alibaba”) and its Tmall Global e-commerce platform whereby the two companies will collaborate to increase the sale of products produced and sold by American companies to the multi-trillion-dollar Chinese consumer market. Alibaba’s Tmall Global e-commerce platform will provide NextPlat customers a turn-key solution through which products can be sold to the Chinese consumer market. The launch of the Florida E-Commerce Development Program is the first in a series of new NextPlat programs designed to assist U.S. businesses in expanding their online sales capabilities to reach new international customers in the Chinese market. NextPlat intends to rapidly expand this unique e-commerce development opportunity to businesses throughout the United States and all of North America, as well as Central and South America. The new development program features NextPlat’s turnkey global e-commerce solution for customers and leverages NextPlat’s relationships with key partners, including Tmall Global, China’s largest cross-border B2C online marketplace.
  • Progressive Care Inc. – In August 2022, NextPlat completed a strategic $7 million investment in Progressive Care Inc. (OTCQB: RXMD), a personalized health care services and technology company. In a news release announcing the investment, NextPlat CEO Charles M. Fernandez noted that the company is “committed to harnessing the power of digital technologies to capitalize on the ongoing digital transformation of Progressive Care and the entire health care industry.” NextPlat intends to accelerate Progressive Care’s digital health care transformation with the launch of a new e-commerce platform for health care products later this year.
  • NextPlat NFT Platform – Building on its existing e-commerce initiatives, NextPlat is working to bridge the gap between tangible and digital e-commerce marketplaces by incorporating burgeoning Web3 technologies. The company intends to launch a fully integrated NFT platform in the coming months that will enable brands to create, manage and authenticate digital assets while serving as a new source of revenue for NextPlat. Through this model, the company will receive a portion of the revenue generated from branded NFT drops, as well as subsequent secondary market transactions.
  • Global Telesat Communications and Orbital SatCom Corp. – Targeting both domestic and international markets, NextPlat’s subsidiaries leverage partnerships with major e-commerce platforms such as Amazon, Alibaba, eBay and Walmart to serve a growing base that includes more than 50,000 corporate, governmental and individual customers. In total, the brands market more than 10,000 individual products, with a focus on satellite-based connectivity solutions. In addition to exploring accretive M&A opportunities, NextPlat aims to diversify its range of products and broaden its geographic footprint moving forward in an effort to better capitalize on the tremendous growth potential in the United States, Europe and Asia.

“Our goal for 2023 and beyond is to leverage our improved operational capabilities and enhanced leadership team as we expand our offerings in communications and connectivity into the high-growth health care market where we intend to launch an array of innovative new offerings,” Fernandez said in a March 2023 news release detailing the company’s record top-line performance. “Although there remain supply chain headwinds and the challenge of global inflation, we are confident that we have the right combination of market-tested expertise, technology and partnerships that will enable us to bring the power of e-commerce to more customers, brands and industries in the United States and abroad.”

Market Opportunity

The rapid growth of e-commerce over the last decade is expected to continue for the foreseeable future. According to data published by Forbes, roughly 20.8% of all retail purchases are expected to take place online in 2023, accounting for total sales of $6.31 trillion worldwide. It total, e-commerce sales are expected to grow by 10.4% YoY in 2023, accounting for a whopping 24% of all retail purchases by 2026.

For NextPlat, existing partnerships in the industry could be key to capitalizing on this growth. The Forbes report indicates that Amazon accounts for roughly 38.7% of e-commerce sales, while sites like Walmart, eBay and Alibaba round out the list of most visited e-commerce websites. Alibaba is especially interesting due to NextPlat’s recent strategic merchant sourcing agreement with Tmall Global. The Chinese market is “mammoth,” as a recent Alizila report noted. The country’s annual online retail sales of physical goods have nearly doubled in the last five years, reaching approximately 13.8 trillion yuan in 2022, which is nearly $2 trillion USD.

The health care portion of the e-commerce market is generating particularly bullish forecasts, bolstered by the continued adoption of the 340B Drug Pricing Program in the U.S., which requires most drug manufacturers to provide outpatient drugs to covered entities at significantly reduced prices. Industry reports suggest that the global health care e-commerce market will expand at a compound annual growth rate of 16.8% from 2022 to 2030, climbing to a value of more than $1.37 trillion by the end of the forecast period.

Management Team

Charles M. Fernandez, CEO, Executive Chairman and Director of NextPlat, has over three decades of experience in identifying profitable start-up and dislocation opportunities, building significant value and executing exit strategies as an entrepreneur and global investor. Successful across multiple sectors, Fortune Magazine actually labeled Fernandez ‘a restructuring whiz’. As President of Fairholme Capital Management, which he joined in 2008, Mr. Fernandez co-managed all three Fairholme funds and brought in a $2 billion gain for shareholders. Throughout his impressive career, he has participated in more than 100 significant mergers, acquisitions and product development projects across multiple industries. Mr. Fernandez was the founder, Chairman and CEO of eApeiron Solutions LLC, a brand protection and e-commerce company in partnership with Alibaba (NYSE: BABA) and Eastman Kodak (NYSE: KODK), which was successfully sold to Smartrac, a unit of Avery Dennison Corp. (NYSE: AVY).

Rodney Barreto is Chairman and CEO of the Barreto Group and Director of Nextplat. Mr. Barreto’s business career spans over 35 years, including his role at the Barreto Group and, earlier, as the founding partner of Floridian Partners LLC, a corporate and public affairs consulting firm recognized by policy makers as one of the top in its industry in Florida. He chaired the Super Bowl Host Committee in 2007, 2010 and 2020, helping to raise more than $100 million for the success of Miami Super Bowls. As a philanthropist and conservationist, Mr. Barreto is also a three-time appointee to the Florida Fish and Wildlife Conservation Commission, where he has served for over 10 years including holding the title of Chairman eight times. He has twice chaired the Annual U.S. Conference of Mayors, was Chairman of the 1999 Breeder’s Cup Championship held in South Florida and was the Chairman of the 1999 Sister Cities International Convention in Miami. Currently, Mr. Barreto is the Membership Chairman of the Florida Council of 100, and a member of the Boards of Fairchild Tropical Botanic Garden, the Baptist Health South Florida Giving Society, the Bonefish and Tarpon Trust, the Guy Harvey Ocean Foundation, and a member of Miami Dade County Schools Superintendent Carvalho’s Business Advisory Council. Prior to his career in public affairs and real estate, Mr. Barreto was a City of Miami police officer and is a member of the Florida Highway Patrol Advisory Council.

NextPlat Corp. (NXPL), closed Tuesday's trading session at $1.37, up 4.5802%, on 65,949 volume. The average volume for the last 3 months is 122,632 and the stock's 52-week low/high is $0.9857/$2.68.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.